Global Taurine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Taurine Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Taurine is an organic compound. It is up to 0.1% of total human body weight, and is a main constituent of bile. Taurine is essential for the heart, the skeletal muscles, the retina, and the nerves. The body makes it from the amino acid cysteine.

Market Overview:

The latest research study on the global Taurine market finds that the global Taurine market reached a value of USD 350.16 million in 2022. It’s expected that the market will achieve USD 502.32 million by 2028, exhibiting a CAGR of 6.2% during the forecast period.
Drivers
Studies have shown that taurine can promote brain development and absorption of calcium, fat and cellulose in infants and young children; it can maintain the physiological function of retina in infants, maintain and enhance vision; can regulate the nerve conduction system; can be lipid and in human body Phosphorus metabolism plays an important physiological and pharmacological role in heart, liver and endocrine function; it can promote metabolism in the body, enhance physical fitness, relieve fatigue and improve work efficiency. The unique physiological and pharmacological functions of taurine have determined its wide application fields and markets in medicine and food additives. The health industry is growing rapidly, and the development space is large, and many international brands are gradually entering the Chinese market. Some pharmaceutical companies and food companies are also developing health industries.

Limitations

The raw material storage tank area of taurine constitutes a major hazard source of primary hazardous chemicals. There are many kinds of flammable, explosive, toxic and corrosive substances. There are fires, explosions, poisoning, chemical burns, leakage of dangerous chemicals, etc. risk. Under the strict environmental supervision situation, it may also have a serious impact on production due to the negligence of environmental protection work. Safety and environmental protection supervision are tightened, which will further increase the company's operating costs.

Region Overview:

From 2023-2028, North America is estimated to witness robust growth prospects.

Company Overview:

The top three companies are Qianjiang Yongan Pharmaceutical, Huanggang Fuchi Pharmaceutical and Jiangyin Huachang Food Additive with the revenue market share of 38.86%, 19.38% and 13.39% in 2018.

Qianjiang Yongan Pharmaceutical

The company was founded in 2001, and became a listed company in Shenzhen Stock Exchange on Mar.5th, 2010. With strong technical development capability, the technology centre is awarded as provincial technology center.We creat Ethylene oxid technology to produce taurine by ourselves.The current production capacity of taurine is 38000MT/year.The output occupies countrywide proportion to exceed 50％.The taurine meets the standard of JP8、JP15、USP32、GB14759-93 and CP2005.The company has completed QMS(Quality management system) and passed GMP、ISO9001:2000 and HACCP.We got the certificates of Kosher、HALAL and Fami-QS.

Fuchi Pharmaceutical Co., Ltd is a wholly owned subsidiary of GRANDPHARMA (CHINA) CO., LTD, and is the most experienced Taurine manufacturer in China. Since 1996, Fuchi has been specialized in Taurine production thereby satisfying customers around the world. Led by the core value of “Offer Good Products, High State of Uniting”, Fuchi is striding towards its own vision of “Maintain a Deputed Pharmaceutical Business Forever, Serve society”. Fuchi enjoys a high reputation among customers domestic and abroad for its excellent products and all-round premium service.

Segmentation Overview:

Among different product types, Food Grade segment is anticipated to contribute the largest market share in 2028.

Application Overview:

By application, the Beverage segment occupied the biggest share from 2018 to 2022.

Key Companies in the global Taurine market covered in Chapter 3:

Sogo Pharmaceutical
Jiangsu Yuanyang Pharmaceutical
Jiangyin Huachang Food Additive
Huanggang Fuchi Pharmaceutical
Qianjiang Yongan Pharmaceutical
Hebi City Hexin Chemical
Taisho Pharmaceutical Holdings

In Chapter 4 and Chapter 14.2, on the basis of types, the Taurine market from 2018 to 2029 is primarily split into:

Food Grade
Pharmaceutical Grade

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Taurine market from 2018 to 2029 covers:

Beverage
Pet Food
Pharmaceuticals
Personal Care Products
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)